Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs Eden

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade A− · #2

Eden

A polished, high-disclosure compounded program with strong nationwide coverage.

Visit Eden

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 91/100 (grade A vs A−). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Eden still earns its place — people who prioritize a vetted, high-transparency provider over the lowest sticker price.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results90
97Price honesty89
96Prescriber access95
88Formulary choice86
95Cancellation fairness90
93Member support92

Price, coverage & features

MetricCoreAge RxEden
Verdict Score94/10091/100
GradeAA−
Semaglutide$149/mo$239/mo
Tirzepatide$349/mo$349/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoNo

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Eden

What we like

  • High verification confidence — clear supply-chain and clinician disclosure
  • Nationwide availability
  • Both molecules offered

The caveats

  • Premium pricing vs the cheapest tiers
  • Compounded only — no brand-name access
  • FDA issued a warning letter to Eden Health International Inc. dba Eden in June 2026; it is public in FDA's warning-letter database

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

People who prioritize a vetted, high-transparency provider over the lowest sticker price.

Visit Eden Read the full Eden review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Eden does the reverse.

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.